Share your videos with the world

Sign Up | Log In | Help  

   
 
Related Tags: general  mills  anniversary  american  innovation  invention  food  industry  company  history  multivu  7728051  lucky  charms  general  mills  luckytobe  diversity  pride  celebration  tumblr  facebook  social  media  campaign  multivu  7235651  cheerios  cereal  breakfast  general  mills  honey  nut  bees  honey  food  nature  multivu  7803951  beyonce  falls  brazil  on  stage  singers  falls  terminator  dark  fate  movie  says  walt  disney  bullshit  hoax  most  amazing  vehicles  donna  mills  hollywood  christmas  parade  carrier  air  conditioning  refrigeration  anniversary  inventor  cooling  system  technology  history  multivu  54996  crimes  wines  john  o  reilly  alcohol  style  convict  old  app  phone  animation  multivu  8159151  robinsons  fruit  shoot  robinsons  fruit  shoot  fruit  shoot  juice  crew  robinsons  juice  crew  juice  teen  extreme  sport  fun  coo  robinsons  fruit  shoot  robinsons  fruit  shoot  fruit  shoot  juice  crew  robinsons  juice  crew  juice  teen  extreme  sport  fun  coo  robinsons  fruit  shoot  robinsons  fruit  shoot  fruit  shoot  juice  crew  robinsons  juice  crew  juice  teen  extreme  sport  fun  coo 
Search // lls
Results 1-9 of 9 for ' lls ' (0 seconds)
Going on the offensive against one of the most daunting challenges in cancer, The Leukemia & Lymphoma Society (LLS) today announced the launch of a groundbreaking, collaborative clinical trial for acute myeloid leukemia (AML), a deadly disease which has seen few improvements in treatments in more than 40 years. Beat AML was announced yesterday by Vice President Biden, along with many new, Moonshot inspired initiatives across industry, non-profit and government. AML is the most lethal of the blood cancers, which together are the third leading cause of cancer deaths in the U.S.; AML is responsible for more than 10,000 deaths each year. Despite advances in treating other blood cancers, the standard of treatment for AML – a combination of toxic chemotherapies – has remained the same for more than 40 years. Overall prognosis remains poor, with a five-year survival rate below 20 percent for patients over age 60. To view the multimedia release go to: http://www.multivu.com/players/English/7554854-lls-beat-aml-acute-myeloid-leukemia/
Categories // Miscellaneous 
Added: 2717 days ago by MultiVuVideos
Runtime: 0m59s | Views: 664 | Comments: 0
Not yet rated
 

 

 

Team In Training. Light The Night. Man & Woman of the Year. Student Series. Leukemia Cup Regatta. More than 13 million participants in these popular fundraising campaigns last year alone helped The Leukemia & Lymphoma Society (LLS) invest more than $1 billion in research to advance lifesaving treatments and cures for blood cancer patients. For Blood Cancer Awareness Month this September, LLS is reminding us that despite progress, much work still needs to be done to save more lives. More than 1.2 million people in the U.S. are living with or in remission from a blood cancer. Leukemia causes more deaths than any other cancer among children, adolescents and adults younger than 20 years. Leukemia, lymphoma and myeloma are expected to cause the deaths of an estimated 58,320 people in the U.S. in 2016. To view the multimedia release go to: http://www.multivu.com/players/English/7554853-lls-blood-cancer-awareness-month/
Categories // Miscellaneous 
Added: 2765 days ago by MultiVuVideos
Runtime: 1m0s | Views: 703 | Comments: 0
Not yet rated
 

 

 

Blood cancers are the third leading cause of cancer deaths in the U.S. However, many Americans are unaware of the impact of these cancers, including leukemia, lymphoma and myeloma, which affect the bone marrow, the blood cells, the lymph nodes and other parts of the lymphatic system. A new survey commissioned by The Leukemia & Lymphoma Society (LLS) reveals more than four in five adults (82%) are surprised that blood cancers are the third leading cancer killer of Americans. Further, nearly four in five adults (78%) are surprised that acute lymphocytic leukemia (ALL) is the most common cancer in children and young adults under age 20. To view the multimedia release go to: https://www.multivu.com/players/English/8128551-lls-blood-cancer-awareness-month/
Categories // Miscellaneous 
Added: 2400 days ago by MultiVuVideos
Runtime: 4m47s | Views: 575 | Comments: 1
Not yet rated
 

 

 

The Leukemia & Lymphoma Society (LLS) today announced it has committed $40.3 million in new research investments to advance the most promising blood cancer science at leading academic and medical centers around the world, including Dana-Farber Cancer Institute in Boston; Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center in New York; MD Anderson Cancer Center in Houston; Fondazione Centro San Raffaele in Milan; and South Australian Health & Medical Research Institute in Adelaide. This $40.3 million investment, comprised of 75 new research grants in LLS’s portfolio of 300 projects, will fund a diverse array of research to find better treatments and cures for patients with leukemia, lymphoma, myeloma and other blood cancers. To view the multimedia release go to: http://www.multivu.com/players/English/7554855-lls-invests-millions-new-research-treatment-cures/
Categories // Miscellaneous 
Added: 2688 days ago by MultiVuVideos
Runtime: 0m47s | Views: 638 | Comments: 0
Not yet rated
 

 

 

The Leukemia & Lymphoma Society (LLS) today announced it has committed $28.6 million in new research investment to advance the most promising blood cancer science at leading academic and medical institutions around the world, including Dana-Farber Cancer Institute, Weill Cornell Medical College and MD Anderson Cancer Center. As LLS leads the charge to find cures for cancer patients, this new funding, along with ongoing investment in LLS’s aggressive research agenda, brings LLS’s total commitment to blood cancer research to more than $1 billion. The investment has led to the development of nearly every therapy currently used to treat the blood cancers. Along with these new research grants, LLS remains committed to collaborating with biotechnology companies through its innovative Therapy Acceleration Program® (TAP), a model pioneered by LLS in the cancer arena in recognition that traditional research approaches weren’t yielding treatments and cures fast enough for patients. LLS commits approximately $13 million a year to its TAP initiatives. As part of the 24 current such collaborations, LLS recently initiated new investments with Kite Pharma and OncoPep. To view the multimedia release go to: http://www.multivu.com/players/English/7554852-lls-cancer-research-funding/
Categories // Miscellaneous 
Added: 3101 days ago by MultiVuVideos
Runtime: 1m4s | Views: 762 | Comments: 0
Not yet rated
 

 

 

Significant advances toward cures for blood cancer patients, many of which were funded by The Leukemia & Lymphoma Society (LLS) over the past 65 years, are among the dramatic highlights featured in Ken Burns presents CANCER: THE EMPEROR OF ALL MALADIES, a film by Barak Goodman, to air on PBS stations nationwide from March 30-April 1. The documentary series is based on the Pulitzer Prize-winning book by Siddhartha Mukherjee, MD, The Emperor of All Maladies: A Biography of Cancer. LLS has been a driving force behind treatment breakthroughs for patients with blood cancers, including leukemia, lymphoma and myeloma. As the world’s largest voluntary health agency dedicated to finding cures for blood cancer patients, LLS has invested more than $1billion in research to advance lifesaving treatments and cures. To view the Multimedia News Release, go to http://www.multivu.com/players/English/7409151-lls-cancer-research-pbs-series/
Added: 3320 days ago by MultiVuVideos
Runtime: 1m5s | Views: 831 | Comments: 2
Not yet rated
 

 

 

The Leukemia & Lymphoma Society (LLS), the world’s leading voluntary non-profit dedicated to blood cancers, released 30 “proof points” - one for each day of September, Blood Cancer Awareness Month - to demonstrate its impact on the cancer landscape and progress towards a world without blood cancers. LLS has invested more than $1 billion in research to advance breakthrough therapies and cures for blood cancer patients. In many cases, those treatments are now helping patients with other cancers and chronic diseases. Due to its focus on blood cancers, survival rates are improving. Since the early 1960s, five-year survival rates for many blood cancer patients have doubled, tripled and even quadrupled. To view the multimedia release go to: http://www.multivu.com/players/English/7554851-lls-blood-cancer-awareness-month/
Categories // Miscellaneous 
Added: 3131 days ago by MultiVuVideos
Runtime: 0m32s | Views: 703 | Comments: 0
Not yet rated
 

 

 

Every three minutes someone in the U.S. is diagnosed with a blood cancer. No one knows this better than “Nashville” star Charles Esten and his wife Patty. Esten’s 15-year-old daughter, Addie, was diagnosed with leukemia at age 2 ½. Naturally, their world was turned upside down. But, they quickly learned that there was hope, based on research to advance new treatments and cures for leukemia, much of it funded by The Leukemia & Lymphoma Society (LLS). To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7491051-charles-esten-light-the-night-walks/
Categories // Miscellaneous 
Added: 3271 days ago by MultiVuVideos
Runtime: 1m0s | Views: 689 | Comments: 0
Not yet rated
 

 

 

As breakthroughs in cancer treatments are occurring at an ever increasing rate, The Leukemia & Lymphoma Society (LLS) is shining a spotlight on the women in science who are helping to lead these advances. Through its significant investment in cancer research – more than $1.2 billion since its founding nearly 70 years ago – LLS is committed to funding and recognizing female scientists, physicians, social workers and nurses, and encouraging young women to participate in STEM (science, technology, engineering and math) education and pursue careers in the sciences. To view the multimedia release go to: https://www.multivu.com/players/English/8128552-lls-women-in-science/
Categories // Miscellaneous 
Added: 2206 days ago by MultiVuVideos
Runtime: 0m45s | Views: 569 | Comments: 5
Not yet rated
 

 

 

Page 1 of 1  |  Go to page   



About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2024 ClipMoon.com. All rights reserved.